IL6 and hepatocellular carcinoma: Moreover, inhibiting the IL‐6‐STAT3/Foxp3 cascade showed immune‐related antitumor effect in hepatocellular carcinoma, wherein IL‐6‐STAT3 signaling inactivation suppressed Foxp3 expression in Tregs.87